Brain metabolite levels in the post-acute stage of anti-NMDA receptor encephalitis and schizophrenia: a longitudinal case-control study.

IF 9.6 1区医学 Q1 NEUROSCIENCES

Biological Psychiatry Pub Date : 2025-07-12 DOI:10.1016/j.biopsych.2025.07.006

Adriana Fortea, María Ortuño, Mireia Masias, Mar Guasp, Elena De la Serna, Thais Armangue, Inmaculada Baeza, Roger Borràs, Laia Prades, Mirea Rosa-Justicia, Heike Stein, Eloy Martínez-Heras, Albert Compte, Sara Llufriu, Josep Dalmau, Josefina Castro-Fornieles, Gisela Sugranyes

引用次数: 0

Abstract

In-vivo assessment of glutamatergic metabolites in patients with anti-NMDA receptor (NMDAR) encephalitis compared to schizophrenia may help understand the pathophysiology of both conditions.

查看原文本刊更多论文

抗nmda受体脑炎和精神分裂症急性期后脑代谢物水平：一项纵向病例对照研究

对比抗nmda受体（NMDAR）脑炎和精神分裂症患者体内谷氨酸代谢产物的评估，可能有助于了解这两种疾病的病理生理学。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Biological Psychiatry 医学-精神病学

CiteScore

18.80

自引率

2.80%

发文量

1398

审稿时长

33 days

期刊介绍： Biological Psychiatry is an official journal of the Society of Biological Psychiatry and was established in 1969. It is the first journal in the Biological Psychiatry family, which also includes Biological Psychiatry: Cognitive Neuroscience and Neuroimaging and Biological Psychiatry: Global Open Science. The Society's main goal is to promote excellence in scientific research and education in the fields related to the nature, causes, mechanisms, and treatments of disorders pertaining to thought, emotion, and behavior. To fulfill this mission, Biological Psychiatry publishes peer-reviewed, rapid-publication articles that present new findings from original basic, translational, and clinical mechanistic research, ultimately advancing our understanding of psychiatric disorders and their treatment. The journal also encourages the submission of reviews and commentaries on current research and topics of interest.